Literature DB >> 28847729

Hepatic GDF15 is regulated by CHOP of the unfolded protein response and alleviates NAFLD progression in obese mice.

Ding Li1, Hua Zhang1, Yuan Zhong2.   

Abstract

The adaptive unfolded protein responses (UPR) initiated by ER stress have been implicated in metabolic dysfunctions and liver diseases. Growth differentiation factor 15 (GDF15) shows a broad range of effects on lipid homeostasis. The functional interconnections between ER stress and GDF15 are still unclear, however. Here we present that hepatic excess lipid accumulation along with ER stress could exacerbate GDF15 expression in mouse liver. Administration of chemical ER stressor tunicamycin to activate the UPR pathway resulted in robust increase of hepatic and circulating GDF15 levels. Further studies revealed that C/EBP-homologous protein (CHOP) of the UPR pathway could directly bind to the promoter of GDF15 and activate its transcription under ER stress conditions both ex vivo and in vivo. Ectopic expression of hepatic GDF15 reduced lipid accumulation in liver and alleviated non-alcoholic fatty liver disease (NAFLD) progression via enhancing hepatic fatty acid β-oxidation in HFD-feeding mice. Together, our results demonstrate that hepatic GDF15 acts as a downstream component of the UPR program and exerts beneficial functions in regulating lipid metabolism of liver.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CHOP; ER stress; GDF15; NAFLD; Obesity

Mesh:

Substances:

Year:  2017        PMID: 28847729     DOI: 10.1016/j.bbrc.2017.08.096

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  GDF-15 in Pulmonary and Critical Care Medicine.

Authors:  Fien M Verhamme; Christine M Freeman; Guy G Brusselle; Ken R Bracke; Jeffrey L Curtis
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

Review 2.  GDF15: a potential therapeutic target for type 1 diabetes.

Authors:  Soumyadeep Sarkar; John T Melchior; Hayden R Henry; Farooq Syed; Raghavendra G Mirmira; Ernesto S Nakayasu; Thomas O Metz
Journal:  Expert Opin Ther Targets       Date:  2022-02-09       Impact factor: 6.902

Review 3.  Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype.

Authors:  Sakthivel Muniyan; Ramesh Pothuraju; Parthasarathy Seshacharyulu; Surinder K Batra
Journal:  Cancer Lett       Date:  2022-03-26       Impact factor: 9.756

Review 4.  GDF15: A Hormone Conveying Somatic Distress to the Brain.

Authors:  Samuel M Lockhart; Vladimir Saudek; Stephen O'Rahilly
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

Review 5.  GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.

Authors:  Dongdong Wang; Emily A Day; Logan K Townsend; Djordje Djordjevic; Sebastian Beck Jørgensen; Gregory R Steinberg
Journal:  Nat Rev Endocrinol       Date:  2021-08-11       Impact factor: 43.330

6.  Heightened levels of plasma growth differentiation factor 15 in men living with HIV.

Authors:  Neeti Agarwal; Claudia E Ramirez Bustamante; Huaizhu Wu; Reina Armamento-Villareal; Jordan E Lake; Ashok Balasubramanyam; Sean M Hartig
Journal:  Physiol Rep       Date:  2022-05

7.  GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury.

Authors:  Khrystyna Platko; Paul F Lebeau; Jae Hyun Byun; Samantha V Poon; Emily A Day; Melissa E MacDonald; Nicholas Holzapfel; Aurora Mejia-Benitez; Kenneth N Maclean; Joan C Krepinsky; Richard C Austin
Journal:  Mol Metab       Date:  2019-06-28       Impact factor: 7.422

Review 8.  Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases.

Authors:  Hyon Seung Yi
Journal:  Endocrinol Metab (Seoul)       Date:  2019-03

9.  Fasting exacerbates hepatic growth differentiation factor 15 to promote fatty acid β-oxidation and ketogenesis via activating XBP1 signaling in liver.

Authors:  Meiyuan Zhang; Weilan Sun; Jin Qian; Yan Tang
Journal:  Redox Biol       Date:  2018-02-01       Impact factor: 11.799

10.  Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy.

Authors:  Susan Kralisch; Annett Hoffmann; Juliane Estrada-Kunz; Michael Stumvoll; Mathias Fasshauer; Anke Tönjes; Konstanze Miehle
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.